Skip to main content
Clinical Trials/NCT00626496
NCT00626496
Recruiting
Not Applicable

Genetic Epidemiology of Lymphoproliferative Disorders

Mayo Clinic1 site in 1 country3,000 target enrollmentApril 1, 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lymphoma, Non-Hodgkin
Sponsor
Mayo Clinic
Enrollment
3000
Locations
1
Primary Endpoint
Risk of blood or lymphoma
Status
Recruiting
Last Updated
6 months ago

Overview

Brief Summary

Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.

Registry
clinicaltrials.gov
Start Date
April 1, 2004
End Date
December 31, 2029
Last Updated
6 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Susan Slager

Professor

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Risk of blood or lymphoma

Time Frame: Ongoing

Study Sites (1)

Loading locations...

Similar Trials